Latest Announcements

ABB India Limited has announced that Kolkata Metro has adopted ABB's electrification and motion control solutions to enhance efficiency and reliability. The 25-year alliance between ABB and Kolkata Metro has helped enhance efficiency, safety, and seamless operations with reduced downtime. ABB's solutions have been deployed across the Kolkata Metro network, including stations and underground tunnels, and have contributed to the efficient operation of the network and support Kolkata Metro's ongoing infrastructure development efforts.

Varroc Engineering Limited has been recognized as the winner of the In-Cabin Infotainment & Connected Technology Award at the inaugural ET AutoTech Awards 2026 for its innovation in VarrocLink, an indigenous, sovereign connectivity ecosystem.

Aye Finance Limited has announced a rating upgrade to IND A+ (Stable Outlook) from India Rating & Research, citing robust asset quality, strong capital buffers, and consistent growth trajectory in micro-enterprise lending.

Shilpa Medicare Limited, through its material subsidiary Shilpa Biologicals Private Ltd, has commissioned a state-of-the-art Antibody-Drug Conjugate (ADC) GMP Manufacturing Facility. This facility is one of India's few integrated sites for ADC Drug Substance production, designed to meet global regulatory standards. Leveraging Shilpa's 25-year expertise in highly potent compounds, this expansion strategically positions the company as a key Contract Development and Manufacturing Organization (CDMO) partner for global biotech and pharmaceutical companies in the high-value oncology segment.

Mayank Cattle Food Ltd has announced that its Board of Directors will meet on July 7, 2026, to consider and approve a proposal for the issue of bonus shares. This decision is subject to requisite approvals. Additionally, the trading window for the company's securities will be closed from June 24, 2026, to July 9, 2026, inclusive, in compliance with insider trading regulations.

Biocon Limited announced that its partner, Duopharma Biotech Berhad, secured multiple insulin contracts valued over MYR 225 million from the Ministry of Health, Malaysia. Biocon's Malaysian subsidiary, Biocon Sdn. Bhd., will supply various insulin products including recombinant human insulin, insulin glargine, and insulin aspart under these contracts, which include a three-year agreement for human insulin (~MYR 155.27 million) and two 2-year agreements for insulin glargine (~MYR 18 million) and insulin aspart (~MYR 52.5 million). This reinforces Biocon's long-standing commitment and presence in Malaysia's diabetes care market.

Biocon Limited announced that its partner, Duopharma Biotech, secured multiple insulin tenders from Malaysia's Ministry of Health, valued at over MYR 225 million. Biocon's Malaysian subsidiary will supply short-acting recombinant human insulin, insulin glargine, and insulin aspart under these contracts, which include a three-year human insulin agreement and two-year agreements for insulin glargine and aspart. This reinforces Biocon's commitment to diabetes care in Malaysia, ensuring continued access to high-quality, cost-effective insulin therapies and strengthening its market presence.

Aye Finance Limited has received an upgrade in its credit ratings from India Ratings and Research (Ind-Ra). The long-term debt instruments and issuer rating were upgraded to 'IND A+/Stable' from 'IND A/Stable', while commercial papers were upgraded to 'IND A1+' from 'IND A1'. This upgrade reflects improved capitalisation from a recent IPO, a strengthened secured loan mix, enhanced profitability buffers, and a more diversified funding profile. The ratings also acknowledge the company's focus on expanding its mortgage product portfolio.

Leapfrog Engineering Services Ltd's equity shares will commence trading on the Bombay Stock Exchange (BSE) effective June 24, 2026, under Scrip Code 544797. This event marks the company's official public market debut, providing liquidity and trading access for investors. The listing typically follows an Initial Public Offering (IPO), significantly enhancing the company's market visibility and its capacity to raise future capital.

Liotech Industries Ltd announced that its equity shares (Scrip Code: 544796) will be officially listed and admitted to dealings on the BSE effective June 24, 2026. This action signifies the company's entry into the public market, allowing its shares to be traded by investors. The listing typically follows an initial public offering (IPO) or other capital-raising efforts, providing liquidity to initial investors.

Diksha Polymers Ltd announced that its equity shares (Scrip Code: 544798) will be listed and admitted to dealings on the BSE, effective from June 24, 2026. This marks the company's public debut, making its shares available for trading on the stock exchange. The listing typically follows an Initial Public Offering (IPO), providing the company with access to public capital markets and enhancing its market visibility.

Tech Mahindra Ltd has announced its 39th Annual General Meeting (AGM) to be held on July 17, 2026, and has enclosed its Integrated Annual Report and Business Responsibility and Sustainability Report for the financial year 2025-26. A key agenda item includes the declaration of a final dividend of ₹36 per equity share, which combined with the interim dividend of ₹15 already paid, totals ₹51 per share for FY2025-26. The AGM will also consider the re-appointment of Dr. Anish Shah as a Non-Executive Director.

Tech Mahindra Limited announced its 39th Annual General Meeting (AGM) to be held on July 17, 2026, through Video Conferencing. The key agenda items include the adoption of audited financial statements for FY2025-26 and the re-appointment of Dr. Anish Shah as a Non-Executive Director. Importantly, the company proposes to confirm an interim dividend of ₹15/- per equity share and declare a final dividend of ₹36/- per equity share for the financial year 2025-26, resulting in a total dividend of ₹51/- per share for the year.

Sigma Advanced Systems Ltd released its Corporate Presentation for June 2026, detailing its transformation into a Tier 1 global Aerospace & Defense player. The company reported strong Q4 FY26 financials with ₹413 Cr revenue, 32% PBT, and 31% PAT. Strategic acquisitions of Nasmyth (Oct 2025) and Export Bridge (Apr 2026) have expanded its capabilities, global market access, and unlocked work transfer to India. The presentation highlights a 90%+ international orderbook extending up to 8 years, strong R&D, and an integrated value chain across defense products, sub-systems, and aerospace components.

SIGMA ADVANCED SYSTEMS LIMITED released its Corporate Presentation for June 2026, outlining its transformation into a Tier 1 Global Aerospace & Defense player. The presentation showcases a diversified portfolio including drones, missile systems, avionics, aero-engines, and airframes, backed by strong R&D, a 90%+ international order book up to 8 years, and a dual manufacturing footprint in UK and India. It highlights strategic acquisitions like Nasmyth and Export Bridge to enhance capabilities and global market access, emphasizing the company's integrated value chain play and strategic partnerships for future growth.

Tech Mahindra Ltd announced its 39th Annual General Meeting (AGM) to be held on July 17, 2026, via video conferencing. The agenda includes adopting the financial statements for FY2025-26, confirming an interim dividend of ₹15/- and proposing a final dividend of ₹36/- per equity share for the same fiscal year. Additionally, the re-appointment of Dr. Anish Shah as a Non-Executive Director will be considered.

Balrampur Chini Mills Ltd has received listing approval from both National Stock Exchange of India Limited and BSE Limited for 9,316,771 equity shares. These shares, with a face value of Re. 1/- each, were issued to promoters and non-promoters on a preferential basis at a price of Rs. 483/- per share (including a premium of Rs. 482/-). This approval finalizes the process of admitting these newly issued shares to dealings on the exchanges.

Balrampur Chini Mills Limited has received listing approval from the National Stock Exchange of India Limited and BSE Limited for 9,316,771 equity shares. These shares, with a face value of Re. 1/- each, were issued at a price of Rs. 483/- per share (including a premium) to promoters and non-promoters on a preferential basis. This approval formalizes the successful completion of the preferential allotment, allowing the newly issued shares to be admitted for trading on the exchanges.

Zydus Wellness Ltd's wholly-owned subsidiary, Zydus Wellness International DMCC (UAE), has incorporated a new step-down wholly-owned subsidiary named Zydus Wellness (EU) Limited in Ireland. The new entity, with an initial share capital of €100, was established on June 23, 2026. Its primary objective is business expansion within the Vitamins, Minerals and Supplements (VMS) industry in Ireland. ZWEL is yet to commence operations and currently has no turnover.

Zydus Wellness Limited announced the incorporation of Zydus Wellness (EU) Limited, a step-down wholly-owned subsidiary in Ireland, on June 23, 2026. This new entity, established by Zydus Wellness International DMCC, UAE (a wholly-owned subsidiary of Zydus Wellness Limited), has a share capital of €100 and is intended for business expansion in the Vitamins, Minerals, and Supplements (VMS) industry. ZWEL is yet to commence operations.